Ongoing Clinical Development of ABX464: ABIVAX Launches ABX464-004 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL
6. WMT
7. ADI
8. MRK
9. MRNA
10. MRVL

Go back to Ongoing Clinical Development of ABX464: ABIVAX Launches ABX464-004 Study
(NASDAQ: ABVX) Delayed: 118.20 -2.36 (1.96%)
Previous Close $120.56    52 Week High $ 
Open $120.00    52 Week Low $ 
Day High $120.11    P/E N/A 
Day Low $116.20    EPS $ 
Volume 1,193,471